ID   RIR2B_HUMAN             Reviewed;         351 AA.
AC   Q7LG56; B4E2N4; Q17R22; Q75PQ6; Q75PQ7; Q75PY8; Q75PY9; Q86YE3;
AC   Q9NPD6; Q9NTD8; Q9NUW3;
DT   21-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   10-MAY-2017, entry version 145.
DE   RecName: Full=Ribonucleoside-diphosphate reductase subunit M2 B;
DE            EC=1.17.4.1;
DE   AltName: Full=TP53-inducible ribonucleotide reductase M2 B;
DE   AltName: Full=p53-inducible ribonucleotide reductase small subunit 2-like protein;
DE            Short=p53R2;
GN   Name=RRM2B; Synonyms=P53R2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), FUNCTION, AND
RP   INDUCTION.
RX   PubMed=10716435; DOI=10.1038/35003506;
RA   Tanaka H., Arakawa H., Yamaguchi T., Shiraishi K., Fukuda S.,
RA   Matsui K., Takei Y., Nakamura Y.;
RT   "A ribonucleotide reductase gene involved in a p53-dependent cell-
RT   cycle checkpoint for DNA damage.";
RL   Nature 404:42-49(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4 AND 5).
RA   Ugai H., Yokoyama K.K.;
RT   "Homo sapiens p53-inducible ribonucleotide reductase small subunit 2
RT   splicing variants.";
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-351 (ISOFORM 6).
RC   TISSUE=Placenta, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=11517226; DOI=10.1074/jbc.M106088200;
RA   Guittet O., Haakansson P., Voevodskaya N., Fridd S., Graeslund A.,
RA   Arakawa H., Nakamura Y., Thelander L.;
RT   "Mammalian p53R2 protein forms an active ribonucleotide reductase in
RT   vitro with the R1 protein, which is expressed both in resting cells in
RT   response to DNA damage and in proliferating cells.";
RL   J. Biol. Chem. 276:40647-40651(2001).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND VARIANT LEU-115.
RX   PubMed=11719458;
RA   Yamaguchi T., Matsuda K., Sagiya Y., Iwadate M., Fujino M.A.,
RA   Nakamura Y., Arakawa H.;
RT   "p53R2-dependent pathway for DNA synthesis in a p53-regulated cell
RT   cycle checkpoint.";
RL   Cancer Res. 61:8256-8262(2001).
RN   [11]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH TP53 AND RRM1.
RX   PubMed=12615712;
RA   Xue L., Zhou B., Liu X., Qiu W., Jin Z., Yen Y.;
RT   "Wild-type p53 regulates human ribonucleotide reductase by protein-
RT   protein interaction with p53R2 as well as hRRM2 subunits.";
RL   Cancer Res. 63:980-986(2003).
RN   [12]
RP   TISSUE SPECIFICITY.
RX   PubMed=14583450;
RA   Zhou B., Liu X., Mo X., Xue L., Darwish D., Qiu W., Shih J., Hwu E.B.,
RA   Luh F., Yen Y.;
RT   "The human ribonucleotide reductase subunit hRRM2 complements p53R2 in
RT   response to UV-induced DNA repair in cells with mutant p53.";
RL   Cancer Res. 63:6583-6594(2003).
RN   [13]
RP   CATALYTIC ACTIVITY, AND SUBUNIT.
RX   PubMed=16376858; DOI=10.1016/j.bbrc.2005.12.019;
RA   Qiu W., Zhou B., Darwish D., Shao J., Yen Y.;
RT   "Characterization of enzymatic properties of human ribonucleotide
RT   reductase holoenzyme reconstituted in vitro from hRRM1, hRRM2, and
RT   p53R2 subunits.";
RL   Biochem. Biophys. Res. Commun. 340:428-434(2006).
RN   [14]
RP   INVOLVEMENT IN PEOA5.
RX   PubMed=19664747; DOI=10.1016/j.ajhg.2009.07.009;
RA   Tyynismaa H., Ylikallio E., Patel M., Molnar M.J., Haller R.G.,
RA   Suomalainen A.;
RT   "A heterozygous truncating mutation in RRM2B causes autosomal-dominant
RT   progressive external ophthalmoplegia with multiple mtDNA deletions.";
RL   Am. J. Hum. Genet. 85:290-295(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH IRON IONS, AND
RP   COFACTOR.
RX   PubMed=19728742; DOI=10.1021/bi9001425;
RA   Smith P., Zhou B., Ho N., Yuan Y.C., Su L., Tsai S.C., Yen Y.;
RT   "2.6 A X-ray crystal structure of human p53R2, a p53-inducible
RT   ribonucleotide reductase.";
RL   Biochemistry 48:11134-11141(2009).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 20-322 IN COMPLEX WITH IRON
RP   IONS.
RG   Structural genomics consortium (SGC);
RT   "Human ribonucleotide reductase, subunit M2 B.";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [18]
RP   VARIANTS MTDPS8A ARG-64; GLU-85 DEL; GLY-194; LYS-194 AND PHE-236.
RX   PubMed=17486094; DOI=10.1038/ng2040;
RA   Bourdon A., Minai L., Serre V., Jais J.-P., Sarzi E., Aubert S.,
RA   Chretien D., de Lonlay P., Paquis-Flucklinger V., Arakawa H.,
RA   Nakamura Y., Munnich A., Roetig A.;
RT   "Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase
RT   (p53R2), causes severe mitochondrial DNA depletion.";
RL   Nat. Genet. 39:776-780(2007).
RN   [19]
RP   VARIANTS MTDPS8A SER-224; ILE-282 AND VAL-317.
RX   PubMed=18504129; DOI=10.1016/j.nmd.2008.04.006;
RA   Bornstein B., Area E., Flanigan K.M., Ganesh J., Jayakar P.,
RA   Swoboda K.J., Coku J., Naini A., Shanske S., Tanji K., Hirano M.,
RA   DiMauro S.;
RT   "Mitochondrial DNA depletion syndrome due to mutations in the RRM2B
RT   gene.";
RL   Neuromuscul. Disord. 18:453-459(2008).
RN   [20]
RP   VARIANTS MTDPS8B HIS-110 AND HIS-121.
RX   PubMed=19667227; DOI=10.1001/archneurol.2009.139;
RA   Shaibani A., Shchelochkov O.A., Zhang S., Katsonis P., Lichtarge O.,
RA   Wong L.J., Shinawi M.;
RT   "Mitochondrial neurogastrointestinal encephalopathy due to mutations
RT   in RRM2B.";
RL   Arch. Neurol. 66:1028-1032(2009).
RN   [21]
RP   VARIANT SER-33.
RX   PubMed=26741492; DOI=10.1371/journal.pgen.1005679;
RA   Kohda M., Tokuzawa Y., Kishita Y., Nyuzuki H., Moriyama Y., Mizuno Y.,
RA   Hirata T., Yatsuka Y., Yamashita-Sugahara Y., Nakachi Y., Kato H.,
RA   Okuda A., Tamaru S., Borna N.N., Banshoya K., Aigaki T.,
RA   Sato-Miyata Y., Ohnuma K., Suzuki T., Nagao A., Maehata H.,
RA   Matsuda F., Higasa K., Nagasaki M., Yasuda J., Yamamoto M.,
RA   Fushimi T., Shimura M., Kaiho-Ichimoto K., Harashima H., Yamazaki T.,
RA   Mori M., Murayama K., Ohtake A., Okazaki Y.;
RT   "A comprehensive genomic analysis reveals the genetic landscape of
RT   mitochondrial respiratory chain complex deficiencies.";
RL   PLoS Genet. 12:E1005679-E1005679(2016).
CC   -!- FUNCTION: Plays a pivotal role in cell survival by repairing
CC       damaged DNA in a p53/TP53-dependent manner. Supplies
CC       deoxyribonucleotides for DNA repair in cells arrested at G1 or G2.
CC       Contains an iron-tyrosyl free radical center required for
CC       catalysis. Forms an active ribonucleotide reductase (RNR) complex
CC       with RRM1 which is expressed both in resting and proliferating
CC       cells in response to DNA damage. {ECO:0000269|PubMed:10716435,
CC       ECO:0000269|PubMed:11517226, ECO:0000269|PubMed:11719458}.
CC   -!- CATALYTIC ACTIVITY: 2'-deoxyribonucleoside diphosphate +
CC       thioredoxin disulfide + H(2)O = ribonucleoside diphosphate +
CC       thioredoxin. {ECO:0000255|PROSITE-ProRule:PRU10014,
CC       ECO:0000269|PubMed:16376858}.
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875;
CC         Evidence={ECO:0000269|PubMed:19728742};
CC       Note=Binds 2 iron ions per subunit. {ECO:0000269|PubMed:19728742};
CC   -!- PATHWAY: Genetic information processing; DNA replication.
CC   -!- SUBUNIT: Heterotetramer with large (RRM1) subunit. Interacts with
CC       p53/TP53. Interacts with RRM1 in response to DNA damage.
CC       {ECO:0000269|PubMed:11517226, ECO:0000269|PubMed:12615712,
CC       ECO:0000269|PubMed:16376858, ECO:0000269|PubMed:19728742,
CC       ECO:0000269|Ref.17}.
CC   -!- INTERACTION:
CC       O43929:ORC4; NbExp=4; IntAct=EBI-9009083, EBI-374889;
CC       Q9H4P4:RNF41; NbExp=3; IntAct=EBI-9009083, EBI-2130266;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Translocates from
CC       cytoplasm to nucleus in response to DNA damage.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q7LG56-1; Sequence=Displayed;
CC       Name=2; Synonyms=Long form;
CC         IsoId=Q7LG56-2; Sequence=VSP_017670;
CC       Name=3; Synonyms=Short form gamma;
CC         IsoId=Q7LG56-3; Sequence=VSP_017669;
CC       Name=4; Synonyms=Short form beta;
CC         IsoId=Q7LG56-4; Sequence=VSP_017668;
CC       Name=5; Synonyms=Short form;
CC         IsoId=Q7LG56-5; Sequence=VSP_017671, VSP_017672;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=6;
CC         IsoId=Q7LG56-6; Sequence=VSP_053585;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed at a high level in skeletal
CC       muscle and at a weak level in thymus. Expressed in epithelial
CC       dysplasias and squamous cell carcinoma.
CC       {ECO:0000269|PubMed:14583450}.
CC   -!- INDUCTION: In response to DNA damage in a wild-type p53/TP53-
CC       dependent manner. {ECO:0000269|PubMed:10716435}.
CC   -!- DISEASE: Mitochondrial DNA depletion syndrome 8A (MTDPS8A)
CC       [MIM:612075]: A disorder due to mitochondrial dysfunction
CC       characterized by various combinations of neonatal hypotonia,
CC       neurological deterioration, respiratory distress, lactic acidosis,
CC       and renal tubulopathy. {ECO:0000269|PubMed:17486094,
CC       ECO:0000269|PubMed:18504129}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Mitochondrial DNA depletion syndrome 8B (MTDPS8B)
CC       [MIM:612075]: A disease due to mitochondrial dysfunction and
CC       characterized by ophthalmoplegia, ptosis, gastrointestinal
CC       dysmotility, cachexia, peripheral neuropathy.
CC       {ECO:0000269|PubMed:19667227}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Progressive external ophthalmoplegia with mitochondrial
CC       DNA deletions, autosomal dominant, 5 (PEOA5) [MIM:613077]: A
CC       disorder characterized by progressive weakness of ocular muscles
CC       and levator muscle of the upper eyelid. In a minority of cases, it
CC       is associated with skeletal myopathy, which predominantly involves
CC       axial or proximal muscles and which causes abnormal fatigability
CC       and even permanent muscle weakness. Ragged-red fibers and atrophy
CC       are found on muscle biopsy. A large proportion of chronic
CC       ophthalmoplegias are associated with other symptoms, leading to a
CC       multisystemic pattern of this disease. Additional symptoms are
CC       variable, and may include cataracts, hearing loss, sensory axonal
CC       neuropathy, ataxia, depression, hypogonadism, and parkinsonism.
CC       {ECO:0000269|PubMed:19664747}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ribonucleoside diphosphate reductase
CC       small chain family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAG65196.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=EAW91842.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/rrm2b/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB036063; BAA92434.1; -; mRNA.
DR   EMBL; AB036532; BAA92493.1; -; Genomic_DNA.
DR   EMBL; AB163437; BAD11774.1; -; mRNA.
DR   EMBL; AB163438; BAD11775.1; -; mRNA.
DR   EMBL; AB166669; BAD12265.1; -; mRNA.
DR   EMBL; AB166670; BAD12266.1; -; mRNA.
DR   EMBL; AB166671; BAD12267.1; -; mRNA.
DR   EMBL; AK001965; BAA92005.1; -; mRNA.
DR   EMBL; AK304354; BAG65196.1; ALT_INIT; mRNA.
DR   EMBL; DC308409; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL137348; CAB70703.2; -; mRNA.
DR   EMBL; DQ027001; AAY29059.1; -; Genomic_DNA.
DR   EMBL; AP001328; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP002907; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471060; EAW91842.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC042468; AAH42468.1; -; mRNA.
DR   EMBL; BC108261; AAI08262.1; -; mRNA.
DR   EMBL; BC117496; AAI17497.1; -; mRNA.
DR   EMBL; BC130628; AAI30629.1; -; mRNA.
DR   CCDS; CCDS34932.1; -. [Q7LG56-1]
DR   CCDS; CCDS55267.1; -. [Q7LG56-2]
DR   PIR; T46249; T46249.
DR   RefSeq; NP_001165948.1; NM_001172477.1. [Q7LG56-6]
DR   RefSeq; NP_001165949.1; NM_001172478.1. [Q7LG56-2]
DR   RefSeq; NP_056528.2; NM_015713.4. [Q7LG56-1]
DR   UniGene; Hs.512592; -.
DR   PDB; 2VUX; X-ray; 2.80 A; A/B=20-322.
DR   PDB; 3HF1; X-ray; 2.60 A; A/B=1-351.
DR   PDB; 4DJN; X-ray; 2.20 A; A/B=13-322.
DR   PDBsum; 2VUX; -.
DR   PDBsum; 3HF1; -.
DR   PDBsum; 4DJN; -.
DR   ProteinModelPortal; Q7LG56; -.
DR   SMR; Q7LG56; -.
DR   BioGrid; 119071; 15.
DR   DIP; DIP-24264N; -.
DR   DIP; DIP-48627N; -.
DR   IntAct; Q7LG56; 2.
DR   STRING; 9606.ENSP00000251810; -.
DR   BindingDB; Q7LG56; -.
DR   ChEMBL; CHEMBL3301398; -.
DR   DrugBank; DB00242; Cladribine.
DR   iPTMnet; Q7LG56; -.
DR   PhosphoSitePlus; Q7LG56; -.
DR   BioMuta; RRM2B; -.
DR   DMDM; 74727333; -.
DR   EPD; Q7LG56; -.
DR   MaxQB; Q7LG56; -.
DR   PaxDb; Q7LG56; -.
DR   PeptideAtlas; Q7LG56; -.
DR   PRIDE; Q7LG56; -.
DR   DNASU; 50484; -.
DR   Ensembl; ENST00000251810; ENSP00000251810; ENSG00000048392. [Q7LG56-1]
DR   Ensembl; ENST00000395912; ENSP00000379248; ENSG00000048392. [Q7LG56-2]
DR   Ensembl; ENST00000519317; ENSP00000430641; ENSG00000048392. [Q7LG56-3]
DR   Ensembl; ENST00000519962; ENSP00000429140; ENSG00000048392. [Q7LG56-4]
DR   Ensembl; ENST00000522394; ENSP00000429578; ENSG00000048392. [Q7LG56-5]
DR   GeneID; 50484; -.
DR   KEGG; hsa:50484; -.
DR   UCSC; uc003ykn.4; human. [Q7LG56-1]
DR   CTD; 50484; -.
DR   DisGeNET; 50484; -.
DR   GeneCards; RRM2B; -.
DR   HGNC; HGNC:17296; RRM2B.
DR   HPA; CAB006854; -.
DR   HPA; HPA028812; -.
DR   MalaCards; RRM2B; -.
DR   MIM; 604712; gene.
DR   MIM; 612075; phenotype.
DR   MIM; 613077; phenotype.
DR   neXtProt; NX_Q7LG56; -.
DR   OpenTargets; ENSG00000048392; -.
DR   Orphanet; 329336; Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy.
DR   Orphanet; 254892; Autosomal dominant progressive external ophthalmoplegia.
DR   Orphanet; 480; Kearns-Sayre syndrome.
DR   Orphanet; 255235; Mitochondrial DNA depletion syndrome, encephalomyopathic form with renal tubulopathy.
DR   Orphanet; 298; Mitochondrial neurogastrointestinal encephalomyopathy.
DR   PharmGKB; PA34866; -.
DR   eggNOG; KOG1567; Eukaryota.
DR   eggNOG; COG0208; LUCA.
DR   GeneTree; ENSGT00390000013305; -.
DR   HOVERGEN; HBG001647; -.
DR   InParanoid; Q7LG56; -.
DR   KO; K10808; -.
DR   PhylomeDB; Q7LG56; -.
DR   TreeFam; TF300465; -.
DR   BRENDA; 1.17.4.1; 2681.
DR   Reactome; R-HSA-499943; Synthesis and interconversion of nucleotide di- and triphosphates.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   SIGNOR; Q7LG56; -.
DR   UniPathway; UPA00326; -.
DR   ChiTaRS; RRM2B; human.
DR   EvolutionaryTrace; Q7LG56; -.
DR   GeneWiki; RRM2B; -.
DR   GenomeRNAi; 50484; -.
DR   PRO; PR:Q7LG56; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000048392; -.
DR   ExpressionAtlas; Q7LG56; baseline and differential.
DR   Genevisible; Q7LG56; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:GOC.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004748; F:ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; IBA:GO_Central.
DR   GO; GO:0009200; P:deoxyribonucleoside triphosphate metabolic process; IEA:Ensembl.
DR   GO; GO:0009263; P:deoxyribonucleotide biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0001822; P:kidney development; IEA:Ensembl.
DR   GO; GO:0006264; P:mitochondrial DNA replication; IEA:Ensembl.
DR   GO; GO:1902254; P:negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator; IEA:Ensembl.
DR   GO; GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome.
DR   GO; GO:0003014; P:renal system process; IEA:Ensembl.
DR   GO; GO:0014075; P:response to amine; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:Ensembl.
DR   CDD; cd01049; RNRR2; 1.
DR   InterPro; IPR009078; Ferritin-like_SF.
DR   InterPro; IPR033909; RNR_small.
DR   InterPro; IPR030475; RNR_small_AS.
DR   InterPro; IPR000358; RNR_small_fam.
DR   PANTHER; PTHR23409; PTHR23409; 1.
DR   Pfam; PF00268; Ribonuc_red_sm; 1.
DR   SUPFAM; SSF47240; SSF47240; 1.
DR   PROSITE; PS00368; RIBORED_SMALL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Disease mutation; DNA damage; DNA repair; DNA replication; Iron;
KW   Metal-binding; Neuropathy; Nucleus; Oxidoreductase; Polymorphism;
KW   Progressive external ophthalmoplegia; Reference proteome.
FT   CHAIN         1    351       Ribonucleoside-diphosphate reductase
FT                                subunit M2 B.
FT                                /FTId=PRO_0000228150.
FT   ACT_SITE    138    138       {ECO:0000255|PROSITE-ProRule:PRU10014}.
FT   METAL       100    100       Iron 1.
FT   METAL       131    131       Iron 1.
FT   METAL       131    131       Iron 2.
FT   METAL       134    134       Iron 1.
FT   METAL       194    194       Iron 2.
FT   METAL       228    228       Iron 2.
FT   METAL       231    231       Iron 2.
FT   VAR_SEQ       1     16       MGDPERPEAAGLDQDE -> MLLLRLPPHRSHASPLDCKLQ
FT                                DRCRKCYSPRSGQACPPALAAAWLRRCERRGGRPRGGRRKE
FT                                LTLGLRPARCSAPGPAKDDAWRPQAG (in isoform
FT                                6). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053585.
FT   VAR_SEQ      17    301       Missing (in isoform 4).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_017668.
FT   VAR_SEQ      17    228       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_017669.
FT   VAR_SEQ      17     68       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_017670.
FT   VAR_SEQ      42     43       FV -> SF (in isoform 5).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_017671.
FT   VAR_SEQ      44    351       Missing (in isoform 5).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_017672.
FT   VARIANT      33     33       P -> S (found in a patient with combined
FT                                respiratory complex deficiencies, muscle
FT                                weakness and hearing loss; unknown
FT                                pathological significance;
FT                                dbSNP:rs387906892).
FT                                {ECO:0000269|PubMed:26741492}.
FT                                /FTId=VAR_076280.
FT   VARIANT      64     64       W -> R (in MTDPS8A; dbSNP:rs515726182).
FT                                {ECO:0000269|PubMed:17486094}.
FT                                /FTId=VAR_046217.
FT   VARIANT      85     85       Missing (in MTDPS8A).
FT                                {ECO:0000269|PubMed:17486094}.
FT                                /FTId=VAR_046218.
FT   VARIANT     110    110       R -> H (in MTDPS8B; dbSNP:rs267607025).
FT                                {ECO:0000269|PubMed:19667227}.
FT                                /FTId=VAR_065122.
FT   VARIANT     115    115       V -> L (in colorectal adenocarcinomas
FT                                cell line; loss of ribonucleotide
FT                                reductase activity).
FT                                {ECO:0000269|PubMed:11719458}.
FT                                /FTId=VAR_025699.
FT   VARIANT     121    121       R -> H (in MTDPS8B; dbSNP:rs267607024).
FT                                {ECO:0000269|PubMed:19667227}.
FT                                /FTId=VAR_065123.
FT   VARIANT     194    194       E -> G (in MTDPS8A; dbSNP:rs515726191).
FT                                {ECO:0000269|PubMed:17486094}.
FT                                /FTId=VAR_046219.
FT   VARIANT     194    194       E -> K (in MTDPS8A; dbSNP:rs121918308).
FT                                {ECO:0000269|PubMed:17486094}.
FT                                /FTId=VAR_046220.
FT   VARIANT     224    224       I -> S (in MTDPS8A; without tubulopathy;
FT                                dbSNP:rs515726196).
FT                                {ECO:0000269|PubMed:18504129}.
FT                                /FTId=VAR_046221.
FT   VARIANT     236    236       C -> F (in MTDPS8A; dbSNP:rs121918309).
FT                                {ECO:0000269|PubMed:17486094}.
FT                                /FTId=VAR_046222.
FT   VARIANT     282    282       M -> I (in MTDPS8A; without tubulopathy;
FT                                dbSNP:rs182614164).
FT                                {ECO:0000269|PubMed:18504129}.
FT                                /FTId=VAR_046223.
FT   VARIANT     317    317       L -> V (in MTDPS8A; without tubulopathy;
FT                                dbSNP:rs515726198).
FT                                {ECO:0000269|PubMed:18504129}.
FT                                /FTId=VAR_046224.
FT   CONFLICT    277    277       M -> V (in Ref. 3; BAA92005).
FT                                {ECO:0000305}.
FT   HELIX        29     31       {ECO:0000244|PDB:4DJN}.
FT   TURN         33     35       {ECO:0000244|PDB:4DJN}.
FT   HELIX        37     39       {ECO:0000244|PDB:4DJN}.
FT   STRAND       42     44       {ECO:0000244|PDB:4DJN}.
FT   HELIX        50     61       {ECO:0000244|PDB:4DJN}.
FT   HELIX        66     68       {ECO:0000244|PDB:4DJN}.
FT   HELIX        74     78       {ECO:0000244|PDB:4DJN}.
FT   HELIX        83    109       {ECO:0000244|PDB:4DJN}.
FT   HELIX       111    114       {ECO:0000244|PDB:4DJN}.
FT   HELIX       118    145       {ECO:0000244|PDB:4DJN}.
FT   HELIX       149    156       {ECO:0000244|PDB:4DJN}.
FT   HELIX       158    161       {ECO:0000244|PDB:4DJN}.
FT   HELIX       163    177       {ECO:0000244|PDB:4DJN}.
FT   STRAND      179    181       {ECO:0000244|PDB:4DJN}.
FT   HELIX       183    195       {ECO:0000244|PDB:4DJN}.
FT   TURN        196    198       {ECO:0000244|PDB:4DJN}.
FT   HELIX       199    210       {ECO:0000244|PDB:4DJN}.
FT   HELIX       215    240       {ECO:0000244|PDB:4DJN}.
FT   HELIX       248    267       {ECO:0000244|PDB:4DJN}.
FT   HELIX       272    275       {ECO:0000244|PDB:4DJN}.
FT   HELIX       279    296       {ECO:0000244|PDB:4DJN}.
FT   HELIX       310    312       {ECO:0000244|PDB:4DJN}.
SQ   SEQUENCE   351 AA;  40737 MW;  6D008687EEF40994 CRC64;
     MGDPERPEAA GLDQDERSSS DTNESEIKSN EEPLLRKSSR RFVIFPIQYP DIWKMYKQAQ
     ASFWTAEEVD LSKDLPHWNK LKADEKYFIS HILAFFAASD GIVNENLVER FSQEVQVPEA
     RCFYGFQILI ENVHSEMYSL LIDTYIRDPK KREFLFNAIE TMPYVKKKAD WALRWIADRK
     STFGERVVAF AAVEGVFFSG SFAAIFWLKK RGLMPGLTFS NELISRDEGL HCDFACLMFQ
     YLVNKPSEER VREIIVDAVK IEQEFLTEAL PVGLIGMNCI LMKQYIEFVA DRLLVELGFS
     KVFQAENPFD FMENISLEGK TNFFEKRVSE YQRFAVMAET TDNVFTLDAD F
//
